150 related articles for article (PubMed ID: 18298087)
21. Mechanisms of mammalian polo-like kinase 1 (Plk1) localization: self- versus non-self-priming.
Lee KS; Park JE; Kang YH; Zimmerman W; Soung NK; Seong YS; Kwak SJ; Erikson RL
Cell Cycle; 2008 Jan; 7(2):141-5. PubMed ID: 18216497
[TBL] [Abstract][Full Text] [Related]
22. Structural basis for recognition of Emi2 by Polo-like kinase 1 and development of peptidomimetics blocking oocyte maturation and fertilization.
Jia JL; Han YH; Kim HC; Ahn M; Kwon JW; Luo Y; Gunasekaran P; Lee SJ; Lee KS; Kyu Bang J; Kim NH; Namgoong S
Sci Rep; 2015 Oct; 5():14626. PubMed ID: 26459104
[TBL] [Abstract][Full Text] [Related]
23. The molecular basis for phosphodependent substrate targeting and regulation of Plks by the Polo-box domain.
Elia AE; Rellos P; Haire LF; Chao JW; Ivins FJ; Hoepker K; Mohammad D; Cantley LC; Smerdon SJ; Yaffe MB
Cell; 2003 Oct; 115(1):83-95. PubMed ID: 14532005
[TBL] [Abstract][Full Text] [Related]
24. P21-activated kinase is required for mitotic progression and regulates Plk1.
Maroto B; Ye MB; von Lohneysen K; Schnelzer A; Knaus UG
Oncogene; 2008 Aug; 27(36):4900-8. PubMed ID: 18427546
[TBL] [Abstract][Full Text] [Related]
25. Cytokinesis and cancer: Polo loves ROCK'n' Rho(A).
Li J; Wang J; Jiao H; Liao J; Xu X
J Genet Genomics; 2010 Mar; 37(3):159-72. PubMed ID: 20347825
[TBL] [Abstract][Full Text] [Related]
26. Phosphopeptides with improved cellular uptake properties as ligands for the polo-box domain of polo-like kinase 1.
Richter S; Neundorf I; Loebner K; Gräber M; Berg T; Bergmann R; Steinbach J; Pietzsch J; Wuest F
Bioorg Med Chem Lett; 2011 Aug; 21(16):4686-9. PubMed ID: 21778054
[TBL] [Abstract][Full Text] [Related]
27. Structure of the catalytic domain of human polo-like kinase 1.
Kothe M; Kohls D; Low S; Coli R; Cheng AC; Jacques SL; Johnson TL; Lewis C; Loh C; Nonomiya J; Sheils AL; Verdries KA; Wynn TA; Kuhn C; Ding YH
Biochemistry; 2007 May; 46(20):5960-71. PubMed ID: 17461553
[TBL] [Abstract][Full Text] [Related]
28. Structures of the wild-type and activated catalytic domains of Brachydanio rerio Polo-like kinase 1 (Plk1): changes in the active-site conformation and interactions with ligands.
Elling RA; Fucini RV; Romanowski MJ
Acta Crystallogr D Biol Crystallogr; 2008 Sep; 64(Pt 9):909-18. PubMed ID: 18703838
[TBL] [Abstract][Full Text] [Related]
29. Pinning down the polo-box domain.
Lee KS; Idle JR
Chem Biol; 2008 May; 15(5):415-6. PubMed ID: 18482691
[TBL] [Abstract][Full Text] [Related]
30. Enhanced cellular uptake of a TAT-conjugated peptide inhibitor targeting the polo-box domain of polo-like kinase 1.
Kim SM; Chae MK; Lee C; Yim MS; Bang JK; Ryu EK
Amino Acids; 2014 Nov; 46(11):2595-603. PubMed ID: 25151148
[TBL] [Abstract][Full Text] [Related]
31. Computational analysis of phosphopeptide binding to the polo-box domain of the mitotic kinase PLK1 using molecular dynamics simulation.
Huggins DJ; McKenzie GJ; Robinson DD; Narváez AJ; Hardwick B; Roberts-Thomson M; Venkitaraman AR; Grant GH; Payne MC
PLoS Comput Biol; 2010 Aug; 6(8):. PubMed ID: 20711360
[TBL] [Abstract][Full Text] [Related]
32. Polo-box domain: a versatile mediator of polo-like kinase function.
Park JE; Soung NK; Johmura Y; Kang YH; Liao C; Lee KH; Park CH; Nicklaus MC; Lee KS
Cell Mol Life Sci; 2010 Jun; 67(12):1957-70. PubMed ID: 20148280
[TBL] [Abstract][Full Text] [Related]
33. Choice of Plk1 docking partners during mitosis and cytokinesis is controlled by the activation state of Cdk1.
Neef R; Gruneberg U; Kopajtich R; Li X; Nigg EA; Sillje H; Barr FA
Nat Cell Biol; 2007 Apr; 9(4):436-44. PubMed ID: 17351640
[TBL] [Abstract][Full Text] [Related]
34. Crystal structure of the polo-box domain of polo-like kinase 2.
Shan HM; Wang T; Quan JM
Biochem Biophys Res Commun; 2015 Jan; 456(3):780-4. PubMed ID: 25511705
[TBL] [Abstract][Full Text] [Related]
35. Functional independency between catalytic activity and subcellular targeting of polo-like kinase-1: phenotypes of ectopic overexpression of various mutants.
Ji JH; Jang YJ
Cell Cycle; 2008 Jun; 7(11):1597-603. PubMed ID: 18560274
[TBL] [Abstract][Full Text] [Related]
36. Molecular interactions of Polo-like-kinase 1 with the mitotic kinesin-like protein CHO1/MKLP-1.
Liu X; Zhou T; Kuriyama R; Erikson RL
J Cell Sci; 2004 Jul; 117(Pt 15):3233-46. PubMed ID: 15199097
[TBL] [Abstract][Full Text] [Related]
37. Cancer Osaka thyroid (Cot) phosphorylates Polo-like kinase (PLK1) at Ser137 but not at Thr210.
Wu B; Jiang P; Mu Y; Wilmouth RC
Biol Chem; 2009 Dec; 390(12):1271-7. PubMed ID: 19804365
[TBL] [Abstract][Full Text] [Related]
38. A new class of peptidomimetics targeting the polo-box domain of Polo-like kinase 1.
Ahn M; Han YH; Park JE; Kim S; Lee WC; Lee SJ; Gunasekaran P; Cheong C; Shin SY; Kim HY; Ryu EK; Murugan RN; Kim NH; Bang JK
J Med Chem; 2015 Jan; 58(1):294-304. PubMed ID: 25347203
[TBL] [Abstract][Full Text] [Related]
39. Switching Polo-like kinase-1 on and off in time and space.
Bruinsma W; Raaijmakers JA; Medema RH
Trends Biochem Sci; 2012 Dec; 37(12):534-42. PubMed ID: 23141205
[TBL] [Abstract][Full Text] [Related]
40. Screening of domain-specific target proteins of polo-like kinase 1: construction and application of centrosome/kinetochore-specific targeting peptide.
Ji JH; Jang YJ
J Biochem Mol Biol; 2006 Nov; 39(6):709-16. PubMed ID: 17129406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
